FTXH Holdings Information

FTXH is an equity ETF with a total of 52 individual holdings. The top holdings are AbbVie stock at 7.61%, Pfizer at 7.56%, Johnson & Johnson at 7.28%, Merck & Co. at 7.25%, and Bristol-Myers Squibb Company at 6.59%.

Total Holdings

Top 10 Percentage

54.91%

Asset Class

Equity

ETF Category

Health

Assets

16.34M

PE Ratio

15.92

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	7.61%	5,306
2	PFE	Pfizer Inc.	7.56%	45,086
3	JNJ	Johnson & Johnson	7.28%	6,301
4	MRK	Merck & Co., Inc.	7.25%	13,271
5	BMY	Bristol-Myers Squibb Company	6.59%	23,661
6	BIIB	Biogen Inc.	4.06%	4,145
7	LLY	Eli Lilly and Company	3.92%	762
8	CAH	Cardinal Health, Inc.	3.55%	3,752
9	AMGN	Amgen Inc.	3.54%	1,940
10	REGN	Regeneron Pharmaceuticals, Inc.	3.53%	961
11	VRTX	Vertex Pharmaceuticals Incorporated	3.53%	1,427
12	UTHR	United Therapeutics Corporation	3.47%	1,249
13	GILD	Gilead Sciences, Inc.	3.41%	4,941
14	VTRS	Viatris Inc.	3.30%	52,906
15	ZTS	Zoetis Inc.	3.20%	3,569
16	JAZZ	Jazz Pharmaceuticals plc	2.24%	2,625
17	ILMN	Illumina, Inc.	1.74%	2,781
18	PTCT	PTC Therapeutics, Inc.	1.60%	3,987
19	INCY	Incyte Corporation	1.50%	2,824
20	CRL	Charles River Laboratories International, Inc.	1.49%	1,369
21	EXEL	Exelixis, Inc.	1.37%	5,561
22	MEDP	Medpace Holdings, Inc.	1.21%	372
23	BMRN	BioMarin Pharmaceutical Inc.	1.11%	3,262
24	ELAN	Elanco Animal Health Incorporated	1.09%	8,644
25	HALO	Halozyme Therapeutics, Inc.	0.90%	2,124

Showing 25 of 52 holdings

Subscribe to see the full list

Activate Now

As of Oct 5, 2025